Back
Krystal Biotech 10K Form
Sell
45
KRYS
Krystal Biotech
Last Price:
182.47
Seasonality Move:
17.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KRYS News And Ratings
See the #1 stock for the next 7 days that we like better than KRYS
KRYS Financial Statistics
Sales & Book Value
| Annual Sales: | $50.7M |
|---|---|
| Cash Flow: | $57.81M |
| Price / Cash Flow: | 92.37 |
| Annual Sales: | $30.80 |
| Price / Book: | 5.92 |
Profitability
| EPS (TTM): | 1.78000 |
|---|---|
| Net Income (TTM): | $52.37M |
| Gross Margin: | $47.61M |
| Return on Equity: | 6.45% |
| Return on Assets: | 6% |
Krystal Biotech Earnings Forecast
Key Krystal Biotech Financial Ratios
- The Gross Profit Margin over the past 3 years for KRYS is 93.90%.
- The Selling, General & Administrative Expenses for KRYS have been equal to 194.09% of Gross Profit Margin.
- The Research & Development expenses have been 91.58% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of KRYS is 21.56% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 2 years.
Krystal Biotech Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KRYS |
| CUSIP: | 501147 |
| Website: | krystalbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 7.97 |
| Quick Ratio: | 7.66 |
Price-to-Earnings
| Trailing P/E Ratio: | 467.41 |
|---|---|
| Forward P/E Ratio: | 26.95 |
KRYS Technical Analysis vs Fundamental Analysis
Sell
45
Krystal Biotech (KRYS)
is a Sell
Is Krystal Biotech a Buy or a Sell?
-
Krystal Biotech stock is rated a Sell
The current Krystal Biotech [KRYS] share price is $182.29. The Score for KRYS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.